V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10434639 | 10032987 | 0 | null | null | 2019-09-07 | 2019-09-07 | Enzalutamide | null | null | ENZALUTAMIDE | 101757718 |
| 10434678 | 10032988 | 0 | null | Palliative (P) | null | 2014-02-18 | null | 02 | N | HYDROXYCARBAMIDE | 101301481 |
| 10434708 | 10032990 | null | 0 | 02 | 2020-03-29 | 2020-03-31 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101764889 |
| 10434720 | 10032992 | 0 | 90.4 | 03 | 2022-01-03 | 2022-01-09 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101638046 |
| 10434742 | 10032994 | 0 | 0 | Palliative (P) | 2022-03-14 | 2022-03-14 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100395433 |
| 10434764 | 10032995 | 0 | 0 | null | 2020-03-26 | 2020-03-26 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101645198 |
| 10434855 | 10032997 | 0 | null | Palliative (P) | null | 2020-07-11 | null | 02 | null | ENZALUTAMIDE | 101359404 |
| 10434873 | 10032998 | 1.7 | 87.5 | 03 | 2019-01-06 | 2019-01-19 | Enzalutamide | 02 | null | ENZALUTAMIDE | 101013243 |
| 10434898 | 10033000 | 0 | null | Palliative (P) | 2020-12-05 | 2020-12-05 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101485259 |
| 10435045 | 10033003 | 0 | 93.4 | Palliative (P) | 2019-12-10 | 2019-12-22 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100614846 |
| 10435073 | 10033007 | 0 | 69.5 | Palliative (P) | 2017-06-10 | 2017-06-10 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101119739 |
| 10435106 | 10033011 | 1.58 | 101 | Neo-adjuvant (N) | 2021-09-21 | 2021-10-10 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100401967 |
| 10435132 | 10033012 | 1.72 | 72 | Palliative (P) | 2019-08-08 | 2019-08-12 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100404654 |
| 10435140 | 10033013 | 1.76 | 85 | null | 2021-09-06 | 2021-09-19 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100851110 |
| 10435179 | 10033014 | 1.66 | 59.8 | null | 2018-04-10 | 2018-04-14 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100404629 |
| 10435181 | 10033015 | 1.6 | 51 | null | 2017-01-08 | 2017-01-15 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101219782 |
| 10435200 | 10033016 | 1.75 | 64 | Disease modification (D) | 2017-08-26 | 2017-08-26 | IBRUTINIB | N | N | IBRUTINIB | 101758036 |
| 10435233 | 10033017 | 1.76 | 85 | Curative (C) | 2017-02-06 | 2017-02-08 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101597282 |
| 10435251 | 10033018 | 1.83 | 78.75 | Curative (C) | 2020-04-23 | 2020-04-24 | IBRUTINIB | 02 | N | IBRUTINIB | 100362229 |
| 10435266 | 10033019 | 1.59 | 96.4 | Palliative (P) | 2017-02-05 | 2017-02-18 | Capecitabine | N | N | CAPECITABINE | 100014783 |
| 10435276 | 10033020 | 1.7 | null | Adjuvant (A) | 2021-10-13 | 2021-10-14 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101604800 |
| 10435277 | 10033021 | 1.65 | null | Palliative (P) | 2018-10-10 | 2018-10-30 | Capecitabine | 02 | N | CAPECITABINE | 101423079 |
| 10435279 | 10033022 | 1.72 | 95 | Palliative (P) | 2019-06-27 | 2019-06-27 | Rituximab | 02 | N | RITUXIMAB | 100930054 |
| 10435282 | 10033023 | 0 | 66.1 | 03 | 2016-09-07 | 2016-09-07 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101457274 |
| 10435291 | 10033024 | 1.75 | 64 | Curative (C) | 2019-10-06 | 2019-10-16 | Capecitabine | 02 | Y | CAPECITABINE | 101241374 |
| 10435303 | 10033025 | 1.8 | 82.9 | 03 | 2019-12-08 | 2019-12-22 | DOCETAXEL + Prednisolone | 02 | N | DOCETAXEL | 100604933 |
| 10435305 | 10033026 | 1.64 | 59.4 | Palliative (P) | null | 2018-12-30 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100942123 |
| 10435310 | 10033027 | 1.58 | 74.9 | Palliative (P) | 2019-09-27 | 2019-10-11 | Rituximab | 02 | N | RITUXIMAB | 101181089 |
| 10435311 | 10033028 | 1.56 | 76.8 | Adjuvant (A) | 2015-11-05 | 2015-11-09 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100003537 |
| 10435313 | 10033029 | 1.6 | 77 | null | 2021-04-19 | 2021-05-04 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100436286 |
| 10435314 | 10033030 | 1.6 | 58.8 | Palliative (P) | 2018-06-12 | 2018-06-12 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100431187 |
| 10435329 | 10033031 | 1.6 | 84 | null | 2016-05-31 | 2016-06-18 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101163572 |
| 10435369 | 10033032 | 1.8 | 51.7 | null | 2021-12-02 | 2021-12-02 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100995853 |
| 10435372 | 10033033 | 1.66 | 96 | Disease modification (D) | 2018-03-02 | 2018-03-23 | Capecitabine + Oxaliplatin 14day | 02 | N | PEMBROLIZUMAB | 100685751 |
| 10435378 | 10033034 | 1.72 | 73 | Palliative (P) | 2014-12-01 | 2014-12-07 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101436470 |
| 10435379 | 10033035 | 1.52 | 76 | Disease modification (D) | 2014-12-02 | 2016-02-08 | IBRUTINIB | 2 | N | IBRUTINIB | 100450506 |
| 10435386 | 10033036 | 1.63 | 82.3 | Curative (C) | 2018-11-10 | 2018-11-10 | Capecitabine + Oxaliplatin 21day | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100306468 |
| 10435397 | 10033037 | 1.67 | 69 | null | 2022-02-07 | 2022-02-14 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101388721 |
| 10435436 | 10033038 | 1.59 | 55.2 | Palliative (P) | null | 2019-02-21 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100749860 |
| 10435440 | 10033039 | 0 | 79 | Curative (C) | 2014-11-28 | 2014-11-28 | Rituximab | 02 | N | RITUXIMAB | 100361095 |
| 10435445 | 10033040 | 1.62 | 73.75 | Curative (C) | 2017-08-28 | 2017-09-05 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100254211 |
| 10435460 | 10033041 | 1.7 | 67.5 | Curative (C) | 2020-10-16 | 2020-11-06 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100361595 |
| 10435465 | 10033042 | 1.67 | 74.3 | 03 | 2016-12-12 | 2016-12-14 | IBRUTINIB | N | N | IBRUTINIB | 101373735 |
| 10435468 | 10033043 | 0 | 66.2 | Adjuvant (A) | null | 2021-10-07 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100772662 |
| 10435475 | 10033044 | 1.63 | 66.6 | 03 | 2020-12-02 | 2020-12-11 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100006067 |
| 10435486 | 10033045 | 1.8 | 73.8 | 03 | 2018-08-12 | 2018-09-04 | Docetaxel | 02 | N | DOCETAXEL | 100001047 |
| 10435487 | 10033046 | 1.76 | 86.6 | Disease modification (D) | 2021-12-26 | 2022-01-23 | Rituximab | N | N | RITUXIMAB | 101821205 |
| 10435521 | 10033047 | 1.57 | 97.4 | null | 2017-07-25 | 2017-07-25 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101784380 |
| 10435523 | 10033048 | 0.02 | 74.1 | Adjuvant (A) | 2019-12-07 | 2019-12-07 | IBRUTINIB | 02 | N | IBRUTINIB | 100355815 |
| 10435526 | 10033049 | 1.69 | 82.8 | Palliative (P) | 2015-11-16 | 2015-11-17 | IBRUTINIB | 02 | N | IBRUTINIB | 101352242 |